Skip to content

Biasing approach/avoidance decisions using Transcranial Ultrasonic Stimulation of the Human Amygdala ventral Striatum

Biasing approach/avoidance decisions using Transcranial Ultrasonic Stimulation of the Human Amygdala ventral Striatum - Biasing approach avoidance behaviour using TUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51624
Enrollment
85
Registered
2022-08-01
Start date
2022-08-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain

Interventions

Transcranial Ultrasound Stimulation aimed at bilateral amygdalae and ventral striatum (in separate sessions).

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Healthy participants between 18-40 years of age; - The ability and agreement to provide informed consent, and the ability to fulfil the study's requirements.

Exclusion criteria

Exclusion criteria: •Under 18 years of age •Current or planned pregnancy •Claustrophobia •A history or brain surgery or serious head trauma •A history of or any close relatives (parents, siblings, children) with epilepsy, convulsion, or seizure •Predisposition for fainting spells (syncope) •A cardiac pacemaker or intra-cardiac lines •An implanted neurostimulator •Implanted medication infusion device •Implanted metal devices or large ferromagnetic fragments in the head or upper body (excluding dental wire),or jewellery/piercing that cannot be removed •Use of a medical plaster that cannot or may not be taken off (e.g., nicotine plaster) •Cochlear implants •Metal in the brain, skull, or elsewhere in your body (fragments, clips, etc.) •Diagnosed neurological or psychiatric disorders •Use of psychoactive (prescription) medication (excluding anti-conception) •Skin disease at intended stimulation sites •The consumption of more than four alcoholic units within 24 hours before participation or any recreational drugs within 48 hours before participation

Design outcomes

Primary

MeasureTime frame
Approach/avoidance choice behaviour as indicated by index-finger button-press will be used to assess the neuromodulatory effects of TUS.

Secondary

MeasureTime frame
Pupil size; Heart rate. These secondary study parameters fall under the blanket approval for standard research (CMO2014/288, version 3; titled: *Imaging Human Cognition*).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)